News on immunohistochemistry and other tissue-based testing methods.
The UK government aims to create six centers specializing in digital pathology, medical imaging or both, working together through a framework agreement.
Inspirata plans to leverage Caradigm's software to accelerate the development of Inspirata's cancer big data platform called Cancer Information Data Trust.
The companies will jointly offer pathology and molecular testing services to PPD's pharmaceutical and biotechnology customers.
Five Prime will use an IHC CDx to analyze the use of investigational drug candidates in patients with advanced gastric or gastroesophageal junction cancer.
The companies will develop the protocols for Lunaphore's microfluidics-based rapid autostaining platform, which is currently in the prototype stage.
